(Q80390223)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17531854%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

review article

1 reference

title

Neuroimaging in multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17531854%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

1 reference

Robert Zivadinov

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17531854%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jennifer L Cox

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17531854%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17531854%20AND%20SRC:MED&resulttype=core&format=json

International Review of Neurobiology

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17531854%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17531854%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

449-474

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17531854%20AND%20SRC:MED&resulttype=core&format=json

Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years.

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Imaging of multiple sclerosis: role in neurotherapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

The clinico-radiological paradox in multiple sclerosis revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

The longstanding MS lesion. A quantitative MRI and electron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

The measurement and clinical relevance of brain atrophy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

A semiautomated measure of whole-brain atrophy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Grey matter pathology in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

The effect of IFNbeta-1b on the evolution of enhancing lesions in secondary progressive MS

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

The distribution of plaques in the cerebrum in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Comparison of MRI pulse sequences for investigation of lesions of the cervical spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Relating neocortical pathology to disability progression in multiple sclerosis using MRI

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Local magnetization transfer ratio signal inhomogeneity is related to subsequent change in MTR in lesions and normal-appearing white-matter of multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Thalamic neurodegeneration in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Evidence of early cortical atrophy in MS: relevance to white matter changes and disability

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Macrophage brain infiltration in experimental autoimmune encephalomyelitis is not completely compromised by suppressed T-cell invasion: in vivo magnetic resonance imaging illustration in effective anti-VLA-4 antibody treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Early structural changes in acute MS lesions assessed by serial magnetization transfer studies

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Resolution-dependent estimates of multiple sclerosis lesion loads

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Magnetization transfer magnetic resonance imaging in the assessment of neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

A preliminary study comparing the sensitivity of serial monthly enhanced MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in primary progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Magnetization transfer imaging to monitor the evolution of MS: A 1-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Diffusion tensor magnetic resonance imaging in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Eight-year follow-up study of brain atrophy in patients with MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Guidelines for using quantitative magnetization transfer magnetic resonance imaging for monitoring treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Magnetic resonance imaging monitoring of multiple sclerosis lesion evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Cortical lesions and brain atrophy in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Enhancing magnetic resonance imaging lesions and cerebral atrophy in patients with relapsing multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Magnetic resonance imaging results of the PRISMS trial: a randomized, double-blind, placebo-controlled study of interferon-beta1a in relapsing-remitting multiple sclerosis. Prevention of Relapses and Disability by Interferon-beta1a Subcutaneously in

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Immunopathogenesis of the multiple sclerosis lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Gray Matter Involvement in Multiple Sclerosis: A New Window into Pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Ring-enchancement in multiple sclerosis: marker of disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Magnetic resonance spectroscopy in the monitoring of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Diffusion MRI in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Magnetization transfer can predict clinical evolution in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

A magnetization transfer MRI study of deep gray matter involvement in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Serial gadolinium-enhanced and magnetization transfer imaging to investigate the relationship between the duration of blood-brain barrier disruption and extent of demyelination in new multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Magnetic resonance imaging predictors of disability in primary progressive multiple sclerosis: a 5-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Evidence for progressive gray matter loss in patients with relapsing-remitting MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Development of hypointense lesions on T1-weighted spin-echo magnetic resonance images in multiple sclerosis: relation to inflammatory activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Grey Matter Pathology in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Serial magnetic resonance imaging in multiple sclerosis: correlation with attacks, disability, and disease stage

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Thalamic neurodegeneration in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Central nervous system atrophy and clinical status in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Role of MRI in multiple sclerosis I: inflammation and lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Role of MRI in multiple sclerosis II: brain and spinal cord atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Clinical-magnetic resonance imaging correlations in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Short-term brain atrophy changes in relapsing–remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979020-7

7 January 2021

10.1016/S0074-7742(07)79020-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17531854%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference